Wednesday, October 09, 2013 10:32:06 AM
Woops...just noticed that I had a typo in my last post about the price the secondary offering was set at. It was $3.15, but I typed $2.15 on my phone for that post. Sorry about any confusion there.
But, yes, the gov't shutdown could very well be the issue here as people are all de-risking in their stocks right now and could be the reason for the sell-off (including all these biotechs going down yesterday and today). At this point, I didn't expect NVAX to keep dipping as much as it has today already, so I wouldn't venture to guess where it's going to stop from here, but I'm ready to buy more at $2.75 or lower if it gets there.
Good luck, Stockwinner and all longs.
But, yes, the gov't shutdown could very well be the issue here as people are all de-risking in their stocks right now and could be the reason for the sell-off (including all these biotechs going down yesterday and today). At this point, I didn't expect NVAX to keep dipping as much as it has today already, so I wouldn't venture to guess where it's going to stop from here, but I'm ready to buy more at $2.75 or lower if it gets there.
Good luck, Stockwinner and all longs.
Recent NVAX News
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 05/15/2026 12:15:24 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/07/2026 09:03:47 PM
- Novavax to Participate in BofA Securities 2026 Health Care Conference • PR Newswire (US) • 05/07/2026 08:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2026 12:00:27 PM
- Novavax Reports First Quarter 2026 Financial Results and Operational Highlights • PR Newswire (US) • 05/06/2026 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/06/2026 11:50:51 AM
- Novavax to Report First Quarter 2026 Financial Results on May 6, 2026 • PR Newswire (US) • 04/29/2026 08:00:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/27/2026 12:00:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/27/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/16/2026 10:13:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 04/16/2026 09:40:20 PM
- Novavax shares rise as activist investor calls for board overhaul • IH Market News • 04/08/2026 02:23:16 PM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 04/08/2026 10:00:09 AM
- Novavax Appoints Dr. Robert Walker as Executive Vice President and Head of Research & Development • PR Newswire (US) • 03/30/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/12/2026 09:00:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2026 10:13:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 11:04:04 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 11:03:17 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 11:02:23 AM
